So far, Trapps GLP-1 animal studies have shown that the hormone produces different effects when its created in different parts of the body
The staff there is sooooo amazing
In this decade, we will now see a new era of clinical trials, specific cardiovascular outcome trials, that will focus on people who are obese or overweight and SELECT was really the first of those trials. A Steppingstone to Tomorrow As Vaduganathan described, many feel the time semaglutide has earned in the spotlight could be short-lived relative to its paradigm-shifting impact on public health
Eligibility is based on BMI and health criteria, not cosmetic goals
Chen W, Wainer J, Ryoo SW, Qi X, Chang R, Li J, et al